Page last updated: 2024-08-17

cholestanol and Apolipoprotein B-100, Familial Defective

cholestanol has been researched along with Apolipoprotein B-100, Familial Defective in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, ZY; Guan, L; Huang, Y; Lei, L; Liu, Y; Ma, KY; Man, SW; Wang, J; Wang, L; Wang, X; Zhao, Y	1
Antikainen, M; Gylling, H; Hedman, M; Ketomäki, A; Miettinen, TA	1
Frohlich, JJ; Moghadasian, MH; Salen, G; Scudamore, CH	1
Koivisto, PV; Miettinen, TA	1

Reviews

1 review(s) available for cholestanol and Apolipoprotein B-100, Familial Defective

Article	Year
Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations. Archives of neurology, 2002, Volume: 59, Issue:4 Topics: Brain Diseases; Chenodeoxycholic Acid; Cholestanol; Diagnosis, Differential; Humans; Hyperlipoproteinemia Type II; Musculoskeletal Diseases; Sitosterols; Tendons; Xanthomatosis	2002

Trials

1 trial(s) available for cholestanol and Apolipoprotein B-100, Familial Defective

Article	Year
Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy. The Journal of pediatrics, 2006, Volume: 148, Issue:2 Topics: Adolescent; Anticholesteremic Agents; Child; Cholestanol; Cholesterol; Desmosterol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Phytosterols; Pravastatin; Sitosterols; Triglycerides	2006

Other Studies

2 other study(ies) available for cholestanol and Apolipoprotein B-100, Familial Defective

Article	Year
Plasma cholesterol-lowering activity of dietary dihydrocholesterol in hypercholesterolemia hamsters. Atherosclerosis, 2015, Volume: 242, Issue:1 Topics: Adipose Tissue; Animal Feed; Animals; Anticholesteremic Agents; Aortic Diseases; Atherosclerosis; Bile Acids and Salts; Cholestanol; Cholesterol; Cholesterol, Dietary; Cricetinae; Drug Evaluation, Preclinical; Feces; Gene Expression Profiling; Hyperlipoproteinemia Type II; Intestinal Absorption; Lipids; Lipoproteins; Liver; Male; Mesocricetus; Metabolic Networks and Pathways; Micelles; Molecular Structure; Organ Size; Plaque, Atherosclerotic; Random Allocation; RNA, Messenger; Sitosterols; Sterols; Viscera	2015
Plasma and biliary cholestanol related to steroid metabolism in familial hypercholesterolemia patients with and without ileal exclusion. Clinica chimica acta; international journal of clinical chemistry, 1988, May-31, Volume: 174, Issue:2 Topics: Bile; Cholestanol; Cholesterol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Ileum; Male; Steroids	1988

Article

Year

Plasma cholesterol-lowering activity of dietary dihydrocholesterol in hypercholesterolemia hamsters.

Atherosclerosis, 2015, Volume: 242, Issue:1

Topics: Adipose Tissue; Animal Feed; Animals; Anticholesteremic Agents; Aortic Diseases; Atherosclerosis; Bile Acids and Salts; Cholestanol; Cholesterol; Cholesterol, Dietary; Cricetinae; Drug Evaluation, Preclinical; Feces; Gene Expression Profiling; Hyperlipoproteinemia Type II; Intestinal Absorption; Lipids; Lipoproteins; Liver; Male; Mesocricetus; Metabolic Networks and Pathways; Micelles; Molecular Structure; Organ Size; Plaque, Atherosclerotic; Random Allocation; RNA, Messenger; Sitosterols; Sterols; Viscera

2015

Plasma and biliary cholestanol related to steroid metabolism in familial hypercholesterolemia patients with and without ileal exclusion.

Clinica chimica acta; international journal of clinical chemistry, 1988, May-31, Volume: 174, Issue:2

Topics: Bile; Cholestanol; Cholesterol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Ileum; Male; Steroids

1988